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Abstract
The glucose Enzyme II transporter complex of the Escherichia coli phosphotransferase system (PTS) exists in at least two
physically distinct forms: a membrane-integrated dimeric form, and a cytoplasmic monomeric form, but little is known
about the physical states of these enzyme forms. Six approaches were used to evaluate protein-protein and protein-lipid
interactions in this system. Fluorescence energy transfer (FRET) using MBP-II
Glc-YFP and MBP-II
Glc-CFP revealed that the
homodimeric Enzyme II complex in cell membranes is stable (FRET
-) but can be dissociated and reassociated to the
heterodimer only in the presence of Triton X100 (FRET
+). The monomeric species could form a heterodimeric species (FRET
+)
by incubation and purification without detergent exposure. Formaldehyde cross linking studies, conducted both in vivo and
in vitro, revealed that the dimeric MBP-II
Glc activity decreased dramatically with increasing formaldehyde concentrations due
to both aggregation and activity loss, but that the monomeric MBP-II
Glc retained activity more effectively in response to the
same formaldehyde treatments, and little or no aggregation was observed. Electron microscopy of MBP-II
Glc indicated that
the dimeric form is larger than the monomeric form. Dynamic light scattering confirmed this conclusion and provided
quantitation. NMR analyses provided strong evidence that the dimeric form is present primarily in a lipid bilayer while the
monomeric form is present as micelles. Finally, lipid analyses of the different fractions revealed that the three lipid species
(PE, PG and CL) are present in all fractions, but the monomeric micellar structure contains a higher percentage of anionic
lipids (PG & CL) while the dimeric bilayer form has a higher percentage of zwitterion lipids (PE). Additionally, evidence for a
minor dimeric micellar species, possibly an intermediate between the monomeric micellar and the dimeric bilayer forms, is
presented. These results provide convincing evidence for interconvertible physical forms of Enzyme-II
Glc.
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Introduction
In previous publications, we identified and partially character-
ized a novel form of the Enzyme II complexes of the bacterial
phosphotransferase system, PTS, which both transports and
phosphorylates its substrates in a single phosphoenol pyruvate
(PEP)-dependent step. The novel form of these enzyme complexes
proved to be localized to the cytoplasm of the E. coli cell and
differed in properties from the previously characterized and more
abundant membrane integrated complexes [1]. The membrane-
integrated form proved to be dimeric while the soluble form was
monomeric [2]. These two fractions could be easily separated by
gel filtration where Peak 1 (the dimer) appeared in the void volume
while Peak 2 (the monomer) was included.
All PTS Enzymes II have been shown to catalyze two vectorial
reactions, the unidirectional PEP-dependent sugar phosphoryla-
tion reaction and a bidirectional transphosphorylation reaction in
which the phosphoryl motiety of an intracellular sugar phosphate
is transferred to an incoming radioactive sugar present initially
extracytoplasmically [3,4]. In this reaction, uptake of the
radioactive sugar is coupled to the export of the sugar motiety of
the intracellular sugar-phosphate in intact cells [4]. The PTS can
phosphorylate sugars in both vectorial and non-vectorial reactions
[5,6]. This fact provides assays for the Enzyme II complexes not
available for most transport systems.
The glucose Enzyme II complex (II
Glc) has been studied in
greatest detail and has been purified using both his-tagged and
maltose-binding protein-fused constructs [1,2,7,8]. The purified
protein also exists in the two states (soluble and membrane
integrated), and in vitro conditions that allow the interconversion of
these two forms have been identified. The same appears to be true
for all of the PTS Enzyme II complexes, and possibly for other
E. coli transporters as well [1,2,9].
In this paper, we use physical methods to characterize and
contrast the soluble versus membrane forms of the glucose
Enzyme II complex. Approaches used include Fluorescence
Resonance Energy Transfer (FRET) [10,11,12], formaldehyde
crosslinking [13,14], cryoelectron microscopy [15,16], Dynamic
Light Scattering (D.L.S.) [17,18] and NMR spectroscopy corre-
lated with catalytic activity measurements [1,2,19]. We also
compare the phospholipid (PL) contents (phosphatidyl ethanol-
amine (PE), phosphatidyl glycerol (PG) and cardiolipin (CL)),
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Glc have a higher anionic PL
content than the membranes. The results clearly suggest that the
soluble II
Glc is present in a micellar structure, and that there are
intermediate states between the monomeric micellar structure and
the fully membrane integrated dimeric bilayer structure, one of
which appears to be a larger dimeric micelle.
Methods
In vitro FRET analyses
Protein-protein interactions of II
Glc was studied by FRET
analysis. The expressed II
Glc was fused at its N-terminus to MBP
and at its C-terminus to either CFP or YFP as the fluorophore.
Construction of pMALE-ptsG-cfp and pMALE-ptsG-yfp
recombinant plasmids. Standard methods were used for
DNA amplification, restriction enzyme digestion, agarose gel
electrophoresis, ligation, and transformation [20].
Cloning of ptsG into the pMAL
TM-c2X plasmid. ptsG was
amplified using a pair of primers that generate an EcoRI restriction
site at the beginning of the gene and a BamHI site at the end of the
gene while removing the stop codon. The forward primer
sequence was 59-cggaattcatgtttaagaatgcatttgcta-39 while the re-
verse primer sequence was 59-cgggatccgtggttacggatgtactcatccat-39.
The recombinant plasmid pMALE-ptsG was used as a template.
The PCR product was electrophoresed, and the band of proper
size was cut out and purified using a gel extraction kit (Biomiga,
USA). The PCR product was digested with and ligated into the
EcoRI/BamHI sites of the pMAL
TM-c2X plasmid. The ligated
mixture was transformed into competent E. coli DH5a cells, where
colonies were obtained. Ten colonies were picked, purified onto
LB/100 mg/ml ampicillin and cultured in 5 ml aliquots of LB/
100 mg/ml ampicillin for plasmid extraction. For verification of
the right clone, the plasmid preps were digested with EcoRI/
BamHI using 5 ml aliquots to detect a band on agarose of size
equivalent to the ptsG gene. The insert within the plasmid that
showed the expected ptsG size was subjected to DNA sequencing
using three primers; the first (forward) was designed near the end
of malE and was of the sequence 59-cagcggtcgtcagactgtcgatg-39, the
second primer (forward) was designed within the ptsG gene and
had the sequence 59-accgtattaagctgcctgagtatc-39 while the third
one (reverse) was within pMAL
TM-c2X downstream the insert and
has the sequence 59-cattcgccattcaggctgcgcaac-39.
Cloning of cfp and yfp into the recombinant plasmid
pMALE-ptsG. cfp and yfp plasmids were separately extracted
from E. coli DH5a harboring these plasmids as follows. The host
strains were grown in 5 ml aliquots of LB/100 mg/ml ampicillin
for 18–24 h. Both cfp and yfp plasmids were extracted from the
cultures obtained using a Biomiga plasmid extraction kit following
the manufacturer’s protocol. The extract yield was checked by
electrophoresis. The coding sequences for cfp and yfp were
separately recovered from their respective plasmids by PCR.
The 59 primer was targeted to the N-end of the gene, and
included the XbaI site. It had the following nucleotide sequence:
59-cgtctagaatggtgagcaagggcgaggagctgttc-39. The 39 primer was
targeted to the C-end of the gene and contained a HindIII site and
of the sequernce: 59-cgaagcttttacttgtacagctcgtccatgccgag-39. The
PCR product was electrophoresed, and the preparations that
showed the proper bands were extracted using a gel extraction kit.
The extracted preps of the cfp and yfp genes were separately ligated
into the XbaI/HindIII sites of the recombinant pMALE-ptsG
plasmid. The ligated reaction mix was transformed into competent
E. coli DH5a cells and plated onto LB/ampicillin (100 mg/ml)
plates. Selected transformants were subjected to plasmid extrac-
tion followed by XbaI/HindIII restriction cutting of the extracted
plasmid preps. The extracted plasmids that showed the proper
restriction maps for cloned cfp and yfp were subjected to DNA
sequencing using the first primer that annealed near the end of
ptsG and of the sequence 59-gcagcgggcgtagtggttg-39, while the
second primer was a reverse primer that annealed downstream the
cloned cfp or yfp gene and was of the sequence 59-
cattcgccattcaggctgcgcaac-39. The resulting constructs are called
pMALE-ptsG-cfp and pMALE-ptsG-yfp. The N-terminus of the ptsG
gene was fused to malE contained in the pMALE plasmid.
Recombinant plasmids pMALE-ptsG-cfp and pMALE-ptsG-yfp
were separately electroporated into E. coli strain BL21DE3.
Production of the MBP-II
Glc-CFP/YFP fusion pro-
teins. Fluorescent fusion proteins were generated essentially as
described by [8]. The recombinant cells were grown in double
strength LB containing 0.2% glucose and induced with 0.5 mM
isopropyl b-D thiogalactoside (IPTG) 2 h before harvesting (12–
14 h incubation period). The cells were harvested by
centrifugation, washed 3x with modified M63 (MM63), pH 7.2,
consisting of (g/l): KH2PO4, 13.3 and (NH4)2SO4, 2 and
resuspended in 35 ml of the same medium containing 2 mM
dithiothreitol (DTT) and 1 mM ethylenediamine tetraacetic acid
(EDTA). The cells were lyzed by passage through a French press
36at 15,000 psi. The unbroken cells and cell debris were removed
by centrifugation at 10,000 RPM for 10 min; then the crude cell
extract was centrifuged using a Beckman ultracentrifuge at
40,000 rpm for 2 h in a Titanium 70 rotor. The 2 h HSS
produced was gel filtered as described by [1,8] and the fractions
corresponding to activity peaks 1 and 2 were separately collected
for purification. Occasionally, peak 2 CFP was obtained using the
whole 2 h HSS of the respective strain grown under the same
conditions except that after 2 h induction, the culture was treated
with 4% paraformaldehyde (pH 10.5) to a final concentration of
0.8% for 30 min, followed by inactivation with 2.5 M glycine
(pH 3.2) to a final concentration of 125 mM (5 min with shaking
under standard growth conditions). The cells were then harvested,
washed with MM63/1 mM DTT/1 mM EDTA and treated as
described before, yielding the 2 h HSS.
Protein and Enzyme assays. Protein concentrations were
determined with the DC Bio-Rad colorimetric protein assay
(Cat. #500-0006) using bovine serum albumin as the standard.
The transphosphorylation (TP) activity was determined as
described by [21]. The substrate was 100 mM[
14C]methyl-
a-glucoside, and the phosphate donor was 10 mM glucose-
6-phosphate.
In vitro FRET analysis of MBP-II
Glc-CFP/MBP-II
Glc-YFP
mixtures. Intra- and interactions between peaks 1 and 2. Protein-
protein interactions of II
Glc in gel filtration peaks 1 and 2
of the 2 h HSS of E. coli BL21DE3(pMAL-ptsG-cfp) and
BL21DE3(pMAL-ptsG-yfp) were studied by FRET analyses. The
MBP-II
Glc-CFP was excited at 436 nm where emission at 488 nm
can be absorbed by MBP-II
Glc-YFP. The excitation of YFP
resulted in emission at 526 nm. The purified protein sample in the
elution buffer (20 mM TrisNHCl, 200 mM NaCl, 1 mM EDTA,
1 mM DTT, 10 mM maltose) was contained in a 100 ml quartz
cuvette. Measurements were carried out in a spectrofluorometer
[Fluorolog-3 (FL 3–22), Jobin yvon Inc. (Horiba group)] with a 2.5
or 3.5 slit for both excitation and emission. For detection of FRET
and protein-protein interactions, the following samples were
examined: (i) CFP fused protein plus YFP fused protein from
either peak 1 or peak 2 were mixed after purification, (ii) CFP
fused protein plus YFP fused protein from either peak 1 or peak
2 were mixed, purified and then analyzed, (iii) CFP fused protein
plus YFP fused protein from peak 1 were mixed, triton treated,
purified and then analyzed, (iv) CFP fused protein plus YFP fused
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and then analyzed, (v) CFP fused protein from peak 2 plus YFP
fused protein from peak 1 were mixed, purified and then analyzed.
Detergent treatment was done using triton X100 at a final
concentration of 0.1% with stirring or shaking at 4uC overnight. In
each case, CFP fused protein alone and YFP fused protein alone
from the corresponding peak and in amounts equivalent to that
present in the mixture under examination were similarly treated
and analyzed. Enzyme purification was conducted by affinity
chromatography on an amylose resin as described by [8]. Columns
containing 12 ml of amylose resin were washed with 8 column
volumes of buffer (20 mM TrisNHCl, 200 mM NaCl, 1 mM
EDTA and 1 mM DTT). After sample loading, each column was
washed with 12 bed volumes of column buffer and eluted with
column buffer containing 10 mM maltose. The pooled fractions
were concentrated in an Amicon concentrator, 30,000 MWCO.
The eluate was centrifuged using a fixed angle rotor at 6,000 rpm
for 25 min. The concentrated samples of mixed or separate peaks
were collected, and their protein concentrations were determined.
The purified preparations were used for FRET analyses. The
samples were excited at 436 nm, and the emission resulting in
each case was monitored over the wave length range 440–700 nm
at 2 nm intervals. The apparent FRET efficiency was calculated as
the ratio of the emission intensities at 526 and 476 nm.
Verification of protein protein interactions between II
Glc molecules of MBP-
EII
Glc-CFP and MBP-EII
Glc-YFP fused proteins. This was carried out
by testing: (i) the addition of un-labeled II
Glc-MBP to different
peak 1 mixes of MBP-II
Glc-CFP/MBP-II
Glc-YFP, (ii) the removal
MBP by specific enzymatic digestion with factor Xa.
For (i), validation of the method was conducted by: (a) testing
the interference of un-labeled II
Glc-MBP (its separate effect on the
emission of labeled MBP-II
Glc-CFP and MBP-II
Glc-YFP), (b)
determining the concentration of II
Glc-MBP which can be used
without interference with the emission of reactants. A control
experiment without un-labeled II
Glc-MBP was carried in parallel.
Peak 1 of E. coli BL21DE3(pMALE-ptsG-cfp) was mixed with the
Peak 1 fraction of BL21DE3(pMALE-ptsG-yfp) in the presence of
unlabeled peak 1 of BL21DE3(pMALE-ptsG). Un-labeled peak 1
of BL21DE3(pMALE-ptsG) was similarly included in the separate
test samples of CFP and YFP. The different mixtures produced
were solubilized with Triton X100 and purified through an
amylose column.
For (ii), digestion with factor Xa was carried out moderately or
excessively. The digestion mixture contained 20 mM Tris-HCl,
pH 8, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 4 mM CaCl2
and 10 mM maltose. Factor Xa was added at 0.1 or 0.2 mgo f
enzyme protein per 1 mg of sample protein. The reaction mixture
was kept at room temperature (23uC) for 12 and 34 h, then
analyzed by 10% SDS gel electrophoresis and FRET measure-
ments. Digestion was also performed at 23uC for 3 days using
0.3 mg of enzyme per 1 mg of sample protein, and the digested
samples were subjected to FRET analyses. Excessive digestion
with factor Xa was carried out in two stages, the first stage with
0.3 mg of enzyme per 1 mg of sample protein for 3 days, and the
second stage at 0.2 mg of enzyme per 1 mg of sample protein for
a further 3 days. Digested samples were subjected to SDS PAGE
which was carried out essentially as described by [8] and FRET
analyses.
Processing and presentation of the data. Emission over the
wavelength range 440–700 nm for YFP alone was subtracted
from that of the CFP plus YFP mixture. Then, the profile
produced (termed corrected CFP) was plotted against the profile of
CFP alone. In such cases, one can detect the change in the CFP
profile in the CFP plus YFP mixture due to the presence of YFP.
In positive FRET, one can see a decrease in the peak at 476–
488 nm and an increase in emission over the range around
526 nm. The ratio of emission at l476/emission at l526 for CFP
alone and CFP in the CFP plus YFP mixture after subtraction of
YFP (corrected CFP) were determined and compared. In positive
FRET, a decrease in the ratio of the emission at l476/emission at
l526 for the corrected CFP was observed as compared to that of
CFP alone.
In vivo cross linking
E. coli strain BW25113DptsGDmalE::km(pMALE-ptsG) (generated
in this study, see NMR methodology below) was grown in double
strength yeast extract-tryptone broth (26 YT, Difco) containing
0.2% glucose and 100 mg/ml ampicillin at 37uC/275 rpm for 8 h.
The cells were induced with IPTG at a final concentration of
0.5 mM for 2 h, and then a 4% paraformaldehyde (PFA) solution
was added to the required concentration. Paraformaldehyde
(polymer of HCHO, Fisher company, used as a source of
formaldehyde) was dissolved in phosphate buffered saline or
distilled water to get a 4% stock solution. To achieve solubility,
NaOH pellets were added to a final pH of about 10.5. Incubation
was continued under the same conditions for 30 min, then PFA
action was stopped by the addition of 2.5 M glycine (pH 3.2) to
the final concentration of 125 mM, and the culture was left under
the same condition for an additional 5–10 minutes. The cells were
harvested immediately, washed 36 with MM63/1 mM DTT/
1 mM EDTA, and then resuspended in the same buffer. The
procedures were completed as described by [1] to get the pellet
fraction and the 2 h HSS (French Press: 36 at 16,000 PSI).
The following preparations: low speed pellet, high speed pellet
and high speed supernatant were obtained and analyzed (as
described before) for protein content and transphosphorylation
activity. The transphosphorylation (TP) assay was done at
100 ml sample fraction and 100 ml of assay substrate (100 mM
[
14C] methyl-a-glucoside/10 mM glucose-6-phosphate), with
a reaction time was 2 h.
In vitro cross linking
The effect of chemical cross linking with formaldehyde on
enzyme II
Glc activity of peaks 1 and 2 obtained from gel filtration
of the 2 h HSS of E. coli strain BW25113DptsGDmalE::km(pMALE-
ptsG) was tested. E. coli cells were cultured and treated as described
under in vivo cross linking except that no paraformaldehyde was
added. The 2 h HSS obtained was gel filtered as described [1] to
yield peaks 1 and 2. A freshly prepared paraformaldehyde stock
solution was added to the required concentration, and the mixture
was left at 37uC for 30 min under shaking conditions. The
formaldehyde reaction was stopped by inactivation with glycine at
125 mM final concentration for 5 min at room temperature (RT).
Particle size characterization by Cryo-electron
microscopy and dynamic light scattering
Particle size characterization of the II
Glc-MBP preparations was
performed by Cryo-electron microscopy (EM) and dynamic light
scattering (DLS). The samples treated included purified II
Glc-MBP
of pellets, peak 1 or peak 2 of E. coli strain BL21DE3(pMAL-ptsG),
each at 1–2 mg/ml protein concentration. The samples were
dissolved in Tris buffer, pH 7.4, containing 1 mM EDTA and
1 mM DTT.
Electron microscopic studies were carried out at the
Cryo-electron microscopy facility (UCSD). Uranyl acetate (2%
aqueous solution) was used as a negative stain. Negative staining
was done on carbon-coated 1000-mesh copper grids that were
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high voltage where the electron potential ionizes the gas within the
chamber, and the negatively charged ions are deposited on the
carbon, giving the carbon film an overall hydrophilic surface)
before staining. One- to 5-ml samples were adsorbed for up to
1 min, the grid was rinsed with 2–3 large drops of ddH2Ot o
remove interfering salts/buffer components, and samples were
then stained with freshly filtered 2% uranyl acetate. The sample
was placed on an electron microscopy grid and was rapidly frozen
at liquid nitrogen temperatures. By maintaining specimens in
liquid nitrogen or kept colder, they can be introduced into the
high-vacuum of the electron microscope column. The grid was
examined on the same day.
Dynamic light scattering (DLS) is a technique used for
measuring the size of molecules and particles undergoing
Brownian motion by observing time-dependent fluctuations in
the intensity of scattered light [22]. In DLS, the sample is
illuminated with a laser beam, and the intensity of the resulting
scattered light produced by the particles fluctuates at a rate that is
dependent upon the size of the particles. Analysis of these intensity
fluctuations yields the diffusion coefficient of the particles and
hence the particle size. This technique is non-invasive and used for
characterizing macromolecules in solution and particles in
suspension [23,24,25].
Measurements were made on a Zetasizer Nano Series in-
strument (Malvern Instruments LTD) at 25uC, and the vis-
cosity value for water was used in all measurements. The
size and percentage of particles (percentage size distribution) were
expressed in terms of intensity, volume or number and
graphed as peaks. Also, the z-average particle size was provided.
TheZ-average is the mean particle size obtained from the diffusion
coefficient; it averages all the particles in the scattering volume and
is therefore sensitive to the presence of large particles [26].
NMR analysis
Bacterial strains. E. coli strain BL21DE3 (pMALE-ptsG) [8]
was used for preparation of different enzyme fractions (pellet,
peak1 and peak 2) that were purified using an affinity amylose
column and used for NMR studies. In some cases, E. coli strain
BW25113DptsGDmalE::km(pMALE-ptsG) (generated in this study)
was also used for affinity purification of II
Glc-MBP from pellet,
peak 1, peak 2 and peak 2 of P1-free 2 h HSS obtained from
lysates of cells subjected to in vivo cross linking. Peak 2 of
P1-free 2 h HSS was obtained from cultures of E. coli strain
BW25113DptsGDmalE::km(pMALE-ptsG) subjected to in vivo cross
linking at 0.8% paraformaldehyde (PFA) added after a 2 h in-
duction with IPTG at 0.5 mM (see above for details).
Generation of the recombinant E. coli strain BW25113-
DptsGDmalE::km(pMALE-ptsG). The recombinant plasmid
pMALE-ptsG [8] was transferred into the double mutant E. coli
strain BW25113DptsGDmalE::km by electroporation. Generation of
the double mutant was carried out principally according to the
procedures of [27]. E. coli strain BW25113, which harbors
a temperature sensitive recombinant plasmid, pKD46, carrying
the gene of the recombinase enzyme, was used for generation of the
double mutant by homologous recombination. The different
primers and plasmids used are listed in Table 1. The kanamycin
(km) gene was separately introduced into BW25113 to replace the
ptsG or malE gene; then it was removed from the resultant ptsG
mutant to give the deletion mutant BW25113DptsG. The DmalE::km
mutation was transferred by P1 phage into the ptsG deletion mutant.
Enzyme purification for NMR study. The fused II
Glc-MBP
was purified from the different fractions (pellet, peak 1, peak 2 or
differentfractionsofP1)essentiallyasdescribedby[8].Nodetergent
was applied to any crude fraction unless specifically stated, and the
pellet fraction was homogenized by magnetic stirring at 4uC for
24 h before loading on a column in diluted form (0.1 mg/ml).
Table 1. Primers and plasmids used in generating the E. coli strain BW25113DptsGDmalE::km double mutant.
Primer code Sequence purpose
PptsG1-P1 59-ctaacctgcaaaaggtcggtaaatcgctgatgctgccggtatccgtactgtgtaggctggagctgcttcg-39
target gene vector
Cloning of the km gene from plasmid
pKD4 to generate the ptsG mutation.
PptsG2-P2 59-tcaggttatcggatttagtaccgaaaatcgcctgaacaccagaaccagcatatgaatatcctccttag-39
target gene vector
PmalE-P1 59-cgatgatgttttccgcctcggctctcgccaaaatcgaaggtaaactgtgtaggctggagctgcttcg-3
target gene vector
Cloning of the km gene for the malE
mutation.
pmalE-P2 59-gtctttcagggcttcatcgacagtctgacgaccgctggcggcgttgatcatatgaatatcctccttag-3
target gene vector
Kt 59-cggccacagtcgatgaatcc-39 Verification of km.
K2 59-cggtgccctgaatgaactgc-39
malE-R 59-gcattacttggtgatacgag-39 Verification of the malE mutation
together with K2.
malE-F 59-cacgagcacttcaccaacaaggac-39 Verification of malE mutation together
with either Kt or male-R.
ptsG-F 59-gcacccatactcaggagcactctc-39 Verification of the ptsG mutation together
with Kt.
Plasmid Purpose
pKD46 Encodes phage lRed recombinase under an inducible promoter, easily curable (temperature sensitive, low number copy) to assist homologous
recombination of the km resistance gene.
pKD20 A helper plasmid encoding the FLP recombinase; also easily curable by growth at 37
oC (temperature sensitive replicons). It contains an
arabinose-inducible ParaBAD promoter and acts on the directly repeated FRT (FLP recognition target) sites flanking the resistance gene.
The transacting II protein is the product of the pir gene.
pKD4 Template plasmid for cloning the km gene; contains an FRT-flanked kanamycin resistance (km) or chloramphenicol resistance (cat) gene.
doi:10.1371/journal.pone.0024088.t001
Micellar Structures of Cytoplasmic IIGlc
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24088NMR experiments. The experiments were conducted using
Varian Mercury NMR 300 (VNMR hg300). The following
conditions were applied: nucleus
31P, nucleus solvent, 10% D2O;
transmittance frequency (Sfrq.), 121.472 MHz, decoupler frequency
(dfrq.), 300.078 MHz; decoupler nucleus, H1; power level for
decoupler (dpwr), 40; acquisition time (at), 1.165 or 1.598 sec;
number of transients (nt), up to 46,000; observed transmittance
power (tpwr), 60; pulse width (pw), 15 ms; line broadening (lb), 150;
spectral width (sw), 27000; temperature (temp), 25, 37 or 45uC. The
31P chemicalshiftreferred to wasthat of85%H3PO4 which was used
in a 5-fold diluted form (17%). The NMR tubes applied were of
NORELL brand (part: S-5-600-7, 5 mm, 600 MHz), distributed by
Cambridge Isotope Laboratories, Inc.
PhospholipidanalysesofdifferentpreparationsofII
Glc-MBP
Strain used, growth conditions and purification of II
Glc-
MBP. BL21DE3 carrying pMALE-ptsG was grown, and the
procedures followed were as described above (see FRET analyses
Table 2. Summary of FRET analyses demonstrating interactions between MBP-II
Glc-CFP and MBP-II
Glc-YFP fused proteins of peaks 1
and 2.
Preparation Mixing condition
CFP/YFP ratio of
fused proteins
Protein concentration
(mg/ml) of the CFP
and YFP fused
protein mixtures
emission at l 476/
emission at l 526
for CFP (control)
emission at l 476/
emission at l 526
for CFP of corrected
CFP (CFP in the CFP
and YFP mixture)
a
FRET result
(arbitrary FRET
intensities)
Peak 1 Purified CFP and YFP
fused proteins were
mixed after purification.
1 0.71 1.91 1.85 Nearly no FRET
0.5 1.9 1.82
1/6 4.93 1.92 1.99
1/10 4.93 1.93 2.05
Crude CFP and YFP
fused proteins were
mixed, and then purified.
1/6 1.87 1.87 1.85 Nearly no FRET
0.94 1.79 1.94
1/10 1.85 1.88 1.79
0.93 1.87 1.77
Crude CFP and YFP
fused proteins were
mixed, detergent treated,
purified and then analyzed.
1/6 2.2 1.96 1.24 Presence of FRET
(36.7%)
1/10 2.49 1.96 1.18 Presence of FRET
(39.8%)
1/20 2.15 1.97 1.08 Presence of FRET
(45.2%)
Purified CFP and YFP
fused proteins were
mixed, detergent
treated and analyzed.
1/6 4.69 1.85 1.97 No FRET
1/10 4.69 1.84 1.94
Peak 2 Purified CFP and YFP
fused proteins were
mixed after purification.
1 0.51 1.9 1.77 Nearly no FRET
1/6 1.64 1.88 1.97
4.85 1.93 1.99
1/21 0.55 1.87 2.8
Crude CFP and YFP
fused proteins were
mixed and then purified.
1/10 1 1.88 1.22 Presence of FRET
(35.1)
1/16 0.61 1.91 1.46 Presence of FRET
(23.6)
Peak1/Peak 2 Crude CFP and YFP fused
proteins from peaks
2 & 1, respectively, were
mixed and then purified.
1/6 8.4 1.93 1.54 Presence of FRET
(20.2)
1/3 11.7 1.89 1.34 Presence of FRET
(29.1)
aThe presence of FRET was indicated by a decrease (.10%) in the ratio of emission at l476/emission at l 526 of corrected CFP (CFP in the CFP and YFP mixture after
subtraction of the contribution due to YFP) as compared to the ratio of emission at l476/emission at l 526 for CFP alone (control).
doi:10.1371/journal.pone.0024088.t002
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and enzyme purification.
Lipid extraction. The total polar lipids from purified II
Glc-
MBP of peaks 1 and 2 and the crude pellet fraction of E. coli strain
BL21DE3(pMALE-ptsG) grown under induced conditions were
extracted. In parallel, and to be used as controls, total polar lipids
of crude pellet fractions of E. coli strains BL21DE3(pMALE-ptsG)
(non induced culture), BL21DE3 and wild type 301 were
prepared. Extraction was conducted according to [28,29] as
follows. An aliquot of 0.5 ml of a sample containing 0.25% MgCl2
was mixed with 3.75 ml methanol by vortexing. Then, 7.5 ml of
CHCl3 was added, the mixture was incubated for 1 h at room
temperature in a shaker, and then phase separation was induced
by adding 2.35 ml of 0.25% aqueous MgCl2. The extract was left
for 10 min at room temperature and then centrifuged at 1000
RPM for 10 min. The lower (CHCl3) phase was collected, and the
upper phase was washed twice, each with 5 ml of the pure solvent
mixture, the composition of which was equivalent to the assumed
composition of the lower phase (CHCl3/methanol/water, 86:14:1,
v/v/v) containing 0.25% MgCl2 by shaking for 15 min.
Combined organic phases were washed twice, each with 10 ml
of the pure solvent mixture, whose composition was equivalent to
that of the upper phase (CHCl3/methanol/water, 3:48:47, v/v/v)
containing 0.25% MgCl2 by gentle stirring at room temp for
30 min. At each step, flushing with nitrogen gas was performed.
Combined organic phases were dried in 1 ml aliquots in a vacuum
centrifuge at 35uC and stored at 220uC.
Lipid analysis by LC/ESI mass spectrometry. Machines
used: LC (Ultrafast Microprotein analyzer, Michron Bioresources,
Inc.) and Mass Spectrometry (Finnigan LC QDECA). The
following analysis parameters were applied: ESI Source Voltage:
24.5 kV,SheathGas Flow:80.0PSI, Auxiliary Gas Flow:20.0PSI,
Capillary Voltage: 215.0 V, Capillary Temperature (C): 275uC.
Phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) analysis.
LC/Mass spectrometry for PE and PG analysis was performed
using a reverse phase column (Clipeus C18, 5 mM, 150X2.1 mm,
P/N: Cs-1521-C185, S/N 971553, Ha/Higgins Analytical, Inc.,
made in USA). Mobile phase A (A) consisted of 50% acetonitrile
(ACN)/50% H2O/20 mM ammonium formate while mobile
phase B (B) consisted of 20% ACN/80% isopropanol/20 mM
ammonium formate. The gradient (0.2 ml/min) was as follows:
0–5 min, 0% B; 5–7 min, 0% B to 100% B; 7–45 min, 100% B;
45–46 min, 100% B to 0% B; 46–50 min, 0% B.
For standard (STD), internal standard (IS) and sample
preparation, methyl alcohol (MeOH) was used for dissolving the
dried materials as well as for dilutions to get the final
concentration, and each of the standards and samples was injected
in pure MeOH. The injected amount of both PE and PG
Figure 1. Fluorescence spectra of purified Peak 1 CFP-II
Glc plus Peak 1 YFP-II
Glc mixture, purified Peak 1 CFP-II
Glc and purified Peak
1 YFP-II
Glc. (A) The two fluorescent proteins were not detergent-treated, but were mixed before purification at a 1:6 ratio (Both; dark line).
Alternatively, the spectrum of pure Peak 1 CFP-II
Glc (CFP, light line) or pure Peak 1 YFP-II
Glc (YFP, dotted line) alone was measured. (B) The spectrum of
the YFP-II
Glc protein was subtracted from the spectrum of the Peak 1 CFP-II
Glc - Peak 1 YFP-II
Glc mixture (Both corrected, dark line). The purified CFP-
II
Glc spectrum is also shown (CFP, light line). (No FRET was observed).
doi:10.1371/journal.pone.0024088.g001
Micellar Structures of Cytoplasmic IIGlc
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24088Figure 2. Fluorescence spectra of purified Peak 1 CFP-II
Glc plus Peak 1 YFP-II
Glc mixture, purified Peak 1 CFP-II
Glc and purified Peak 1
YFP-II
Glc. (A) The two fluorescent proteins were mixed before purification at a 1:6 ratio, detergent treated and then purified (Both, dark line).
Alternatively, the spectrum of pure Peak 1 CFP-II
Glc (CFP, light line) or Peak 1 YFP-II
Glc (YFP, dotted line) alone was treated similarly before the spectrum
was measured. (B) The spectrum of the YFP-II
Glc protein was subtracted from the spectrum of the Peak 1 CFP-II
Glc - Peak 1 YFP-II
Glc mixture (Both
(corrected), dark line). The purified CFP-II
Glc spectrum is also shown (light line). FRET was observed due to detergent treatment preceding purification.
doi:10.1371/journal.pone.0024088.g002
Figure 3. Fluorescence spectra of Peak 2 CFP-II
Glc (hereafter designated ‘‘CFP’’) plus Peak 2 YFP-II
Glc (hereafter designated ‘‘YFP’’).
(A) The two fluorescent proteins were mixed at a ratio of 1:10 before purification (dark line). The light and dotted lines show the spectra for purified
Peak 2 CFP and Peak 2 YFP, respectively as indicated. (B) Corrected fluorescence spectra of Peak 2 CFP plus Peak 2 YFP (mixed at a ratio of 1:10 before
purification) (both, dark line) and purified Peak 2 CFP alone (light line). FRET was observed in the absence of detergent treatment.
doi:10.1371/journal.pone.0024088.g003
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internal standard, 5 ng. Between assay runs, the system was
flushed with mobile phase B for 10 min followed by mobile phase
A for another 5 min. The standards/internal standards mixture
was run both at the beginning and at the end of the assay. For
sample analysis, both PE (50 ng) and PG (5 ng) internal standards
were included in the injected samples. For phospholipids
quantitation, Xcalibur 1.3 software from the Thermo Finnigan
Corporation was used.
Cardiolipin (CL) analysis. Cardiolipin was analyzed according
to[30] using normal phase column (Microsorb Si HPLC column,
Cat.# 80–125, serial # 10011, Rainin instrument company, Inc.).
Mobile phase A consisted of methanol/water, 9:1 with 0.1 ml per
liter of 25% aqueous ammonia. Mobile phase B consisted of
CHCl3 with 0.1 ml per liter of 25% aqueous ammonia. For
sample and standard preparation, the dried lipid was dissolved in
a solution consisting of 80% mobile phase B and 20% mobile
phase A. The flow rate applied was 800 ml/min. A flow splitter
after LC and before mass spectrometer was applied, so 12.5% of
the sample (100 out of 800 ml) went to the mass spectrometer. The
gradient (0.8 ml/min) was as follows: 0–4 min, 80% B; 4–10 min,
80% B to 50% B; 10–15 min, 50% B to 0% B; 15–17 min, 0% to
80% B; 17–20 min, 80% B. The injected amount of cardiolipin
(CL) standard was 300 ng, and CL internal standard was 150 ng.
Between assay runs, the system was flushed with mobile phase A
for 5 min followed by mobile phase B for another 10 min. The
standard/internal standard mixture was run both at the beginning
and at the end of the assay. For sample analysis, 150 ng internal
standard was included in the injected samples.
For phospholipid quantitation, Xcalibur 1.3 software from the
Thermo Finnigan Corporation was used.
Results
In vitro FRET analyses of MBP-II
Glc-CFP/MBP-II
Glc-YFP
mixtures
The expressed II
Glc, fused at its N-terminus to the maltose-
binding protein, MBP, and at its C-terminus to either cyan-
fluorescent protein, CFP, or yellow-fluorescent protein, YFP, in the
2 h high speed supernatant (HSS), was gel filtered to produce peaks
1 and 2. The fused proteins, either CFP or YFP, were purified
separately or after mixing as described under Methods. For each
peak, and for both peaks together, fluorescent resonance energy
transfer, FRET, analyses of the MBP-II
Glc-CFP/MBP-II
Glc-YFP
mixtures were carried out. FRET analyses of mixtures of Peak 1
(P1)-CFP and P1-YFP fused proteins, mixed either before or after
purification, were carried out at CFP/YFP ratios of 1/1, 1/6, 1/10
and 1/20 (some are presented in Table 2) and the results revealed
that inno case wasa FRET signalobserved. When mixingwasdone
before purification and at a CFP/YFP ratio of 1/6 (total protein
concentration of 1.87 mg/ml), the emission profiles of the mixed
CFPand YFPfusion proteinsaswellastheirindividualcounterparts
are shown in Figure 1A while the emission profiles of the corrected
CFP in the CFP plus YFP fused protein mixture and CFP fused
Figure 4. Fluorescence spectra of Peak 2 CFP plus Peak 1 YFP. (A) The two fluorescent proteins were mixed at a ratio of 1:6 before purification
(dark line), and purified Peak 2 CFP and Peak 1 YFP were examined alone as indicated (light and dotted lines, respectively). (B) Fluorescence spectra of
corrected Peak 2 CFP plus Peak 1 YFP (Both corrected, dark line) and Peak 2 CFP alone (CFP, light line).
doi:10.1371/journal.pone.0024088.g004
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emission at l526 ratio for the donor (CFP) alone was 1.87. The
same ratio for the CFP + YFP mixture after subtracting the
contribution due to YFP (corrected CFP) was 1.85. The emission
measurements were repeated at various concentrations of total
protein and various ratios as mentioned above, but in no case was
FRET observed (Table 2). Therefore, there is no evidence that II
Glc
subunits of the two preparations have undergone shuffling.
FRET analyses were then performed with mixtures of CFP and
YFP fusion proteins of peak 1, mixed, detergent-treated and
purified before analyses (CFP/YFP ratios as before). At a CFP/
YFP ratio of 1/6, the peak 1 CFP fused protein was mixed with
the peak 1 YFP fused protein and treated with Triton X100 as
described under Methods. The mixture was purified (amylose
resin), and subjected to FRET analyses. The total protein
concentration of the purified preparation of the mixed CFP and
YFP fused proteins was 2.2 mg/ml. The emission profiles of the
individual and mixed CFP and YFP fusion proteins are shown in
Figure 2A while the emission profiles of the corrected CFP fusion
protein for the mixture and for the CFP fusion protein alone are
presented in Figure 2B. The emission at l476/emission at l526
ratio for the donor (CFP) was 1.96, while that of the corrected CFP
was 1.24. The presence of FRET indicates the formation of hetero
II
Glc-YFP/II
Glc-CFP dimers.
Table 4. FRET analyses of positive FRET samples of MBP-II
Glc-CFP/YFP of peak 1 after digestion with factor Xa.
Experiment Digestion condition
Ratio of emission
at l 476/emission
at l 526 for CFP
Ratio of emission at l
476/emission at l 526 for
corrected CFP (CFP in the
CFP and YFP mixture)
a FRET result
Control I No digestion 1.94 1.17 Positive FRET
factor Xa- digested
sample (I)
Digestion was carried out at 0.3 mg of enzyme protein per
1 mg of sample protein for 3 days (Moderate digestion).
2 1.38 Positive FRET
Control II No digestion 1.9 1.14 Positive FRET
factor
Xa- digested
sample (II)
Digestion was carried out in two stages, the first stage at
0.3 mg of enzyme protein per 1 mg of sample protein for
3 days followed by a second digestion at 0.2 mg of enzyme
protein per 1 mg of sample protein for a further 3 days
(Excessive digestion).
1.97 1.97 No FRET
aThe presence of FRET was indicated by a decrease (.10%) in the ratio of emission at l 476/emission at l 526 for the corrected CFP (CFP in the CFP and YFP mixture
after subtraction of the contribution due to YFP) as compared to the ratio of emission at l 476/emission at l 526 for CFP alone (control).
doi:10.1371/journal.pone.0024088.t004
Table 3. Summary of FRET analyses of interactions between MBP-II
Glc-CFP and MBP-II
Glc-YFP fused proteins of peak 1 in the
presence of different concentrations of un-labeled II
Glc-MBP.
Experiment
Protein
amount of
crude MBP-
II
Glc-CFP
(mg)
Protein
amount of
crude MBP-
II
Glc-YFP
(mg)
Protein
amount of
crude un-
labeled
MBP-II
Glc.
(mg)
Ratio of emission
at l 476/emission
at l 526 for CFP
Ratio of emission
at l 476/emission
at l 526 for YFP
Ratio of emission
at l 476/emission
at l 526 for
corrected CFP
(CFP in the CFP
and YFP mixture)
a
-Interference of
added un-labeled
II
Glc-MBP with the
emission of
reactants-FRET
result
Exp. a
(control)
5.2 26 0.0 1.94 0.032 1.43 -Positive FRET
Exp. b 5.2 26 9.5 1.87 0.034 1.39 -No interference,
-Positive FRET
Exp. c 5.2 26 19.1 1.95 0.026 1.48 -No interference,
-Positive FRET
Exp. d 5.2 26 32.3 1.93 0.036 2.38 -No interference,
-No FRET
Exp. e 5.2 26 64 1.97 0.0378 2.95 -No interference,
-No FRET
Exp. f 5.2 26 73.5 1.78 0.062 2.005 -Little interference,
-No FRET,
Exp. g 5.2 26 96.5 1.77 0.087 1.94 -Little interference,
-No FRET
Exp. h 5.2 26 338.1 1.43 0.084 2.24 -Interference of added
un-labeled II
Glc-MBP
with the emission of
reactants.
aThe presence of FRET was indicated by a decrease (.10%) in the ratio of emission at l 476/emission at l 526 for the corrected CFP (CFP in the CFP and YFP mixture
after subtraction of the contribution due to YFP) as compared to the ratio of emission at l 476/emission at l 526 for CFP alone (control).
doi:10.1371/journal.pone.0024088.t003
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regardless of the protein concentrations and ratios used, FRET
was always observed if the mixture was purified on the amylose
column after but not before mixing. For example, in the case of
peak 2, with a CFP/YFP ratio of 1/10, and where the mixture was
subjected to amylose affinity purification, the emission profiles of
the mixed CFP and YFP fused proteins as well as their individual
counterparts are shown in Figure 3A while the emission profiles of
the corrected CFP fused protein in the CFP and YFP fused protein
mixture and the CFP fusion protein alone are shown in Figure 3B.
The emission ratio at wavelengths 476 and 526 nm for the donor
(CFP) was 1.88 and for the corrected CFP of the mixture, it was
1.22, showing that FRET was observed.
For peak 2/peak 1, with a CFP/YFP ratio of 1/6 and with the
mixture subjected to amylose affinity purification, the emission
profiles of the mixed CFP and YFP fused proteins as well as their
individual counterparts are shown in Figure 4A while the emission
profiles for the corrected CFP fused protein in the CFP and YFP
fused protein mixture and the CFP fusion protein alone were
shown in Figure 4B. The emission ratio at wavelengths 476 and
526 nm for the donor (CFP) was 1.93 and for the corrected CFP
was 1.54, showing that FRET was observed. These and other
results using the same approach are summarized in Table 2.
As reported previously [31] the inner membrane proteins (IMPs)
in Gram negative bacteria like E. coli become inserted into the
membrane with the aid of certain mediator proteins. YidC has been
identified as a factor that assists in the integration, folding, and
assembly of IMPs, both in association with the Sec-translocon and
separately. Our results suggest that this can also occur in vitro
Figure 5. SDS PAGE of factor Xa digested samples of MBP-II
Glc-
CFP/MBP-II
Glc-YFP. M. W., molecular weight markers; C, factor Xa
undigested sample; 12 h a & b, samples were digested for 12 h with 0.1
and 0.2 mg enzyme/mg sample protein, respectively; 34 h a & b, samples
were digested for 34 h with 0.1 or 0.2 mg enzyme/mg of sample protein,
respectively.
doi:10.1371/journal.pone.0024088.g005
Figure 6. SDS PAGE of FRET positive samples digested with
factor Xa of MBP-II
Glc-CFP/MBP-II
Glc-YFP. Samples were applied at
1 mg protein per lane. Digestion was carried out in two stages, the first
stage at 0.3 mg of enzyme protein per mg of sample protein for 3 days,
and the second stage at 0.2 mg of enzyme protein per mg of sample
protein for a further 3 days.
doi:10.1371/journal.pone.0024088.g006
Figure 7. Effect of in vivo cross linking with different
concentrations of paraformaldehyde (PFA) on the protein
concentration of different preparations obtained from the cell
lysate of E. coli strain BW25113DptsGDmalE::km(pMALE-ptsG).
Low speed pellets, white bars; high speed pellets, black bars; high
speed supernatants, grey bars. Thin lines above the histograms
represent the standard deviations (S.D).
doi:10.1371/journal.pone.0024088.g007
Micellar Structures of Cytoplasmic IIGlc
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24088between the cytoplasmic form of II
Glc and the bilayer dimeric
membranous form of II
Glc. In this regard [32] reported that the
prokaryotic signal recognition particle receptor (SR) consists of FtsY
and strikingly, although FtsY requires membrane contact for
functionality, cell fractionation studies have localized FtsY predom-
inantly to the cytosolic fraction of E. coli cells. It has been suggested
that the prokaryotic SR might bind the signal recognition particle-
SRP-ribosome-nascent chain complex (SRP-RNCs) already in the
cytosol, and only then does it initiate membrane targeting. In their
report [33], showed that membrane protein targeting in bacteria is
mediated by the signal recognition particle (SRP), FtsY and the
bacterial SRP receptor (SR). They found that 30% of FtsY in E. coli
are found stably associated with the cytoplasmic membrane. This
could explain in part our observation of the interaction of the II
Glc
monomeric form with the membraneous form containing the FtsY
mediator. However, this interaction may be a spontaneous,
unassisted integration process. Further evidence for protein-protein
interactions between II
Glc monomers was obtained.
Testing the addition of un-labeled II
Glc-MBP to different
mixtures of MBP-II
Glc-CFP/MBP-II
Glc-YFP. Table 3 shows
FRET analyses of interactions between MBP-II
Glc-CFP and MBP-
II
Glc-YFP fused proteins of peak 1 in the presence of different
concentrations of un-labeled II
Glc-MBP of the same peak. It is
obvious that incorporation of un-labeled MBP-II
Glc at low
concentration had no appreciable effect on FRET signal
detection (experiments b & c) while increasing its amount to
32.3 mg abolished the FRET signal without causing interference
with the emissions of CFP and YFP alone (exp. d & e). Under the
conditions of these two experiments, the ratio of emission at l
476/emission at l 526 for CFP alone ranged around 1.9, and that
for YFP alone ranged around 0.03. Higher amounts of added un-
labeled MBP-II
Glc ($73.5 mg) caused interference in the emission
of CFP alone (the ratio of emission at l 476/emission at l 526 for
CFP ranged between 1.7721.43) and for YFP alone (the ratio of
emission at l 476/emission at l 526 for YFP ranged between
0.06–0.8) with no FRET signal (exp. f, g & h). Accordingly, this
interference invalidated these three experiments, and the ratio of
emission at l 476/emission at l 526 of corrected CFP (CFP in the
CFP and YFP mixture) showed fluctuating values.
Verification was achieved by examination of specific enzy-
matic removal of MBP on the positive FRET signal of the
Figure 8. Effect of in vivo cross linking with different
concentrations of paraformaldehyde (PFA) on transphosphor-
ylation (TP) activity of different preparations obtained from
the cell lysate of E. coli strain BW25113DptsGDmalE::km(pMALE-
ptsG). Low speed pellets, white bars; high speed pellets, black bars;
high speed supernatants, grey bars. Thin lines above the histograms
show the error bar (S.D). Values are expressed in percentage of original
samples.
doi:10.1371/journal.pone.0024088.g008
Figure 9. Transphosphorylation (TP) activities of gel filtration
fractions of 2 h high speed supernatants prepared from
cultures of E. coli strain BW25113DptsGDmalE::km(pMALE-ptsG)
that were subjected to in vivo cross linking with paraformal-
dehyde (PFA) at 0.3, 0.6 and 1.2%. Control, x’s; 0.3% PFA, squares;
0.6% PFA, triangles; 1.2% PFA, diamonds.
doi:10.1371/journal.pone.0024088.g009
Figure 10. Protein profile of gel filtration fractions of a 2 h high
speed supernatant prepared from a culture of E. coli strain
BW25113DptsGDmalE::km(pMALE-ptsG) that were subjected to
in vivo cross linking with paraformaldehyde (PFA) at 0.3, 0.6
and 1.2%. Control, x’s; 0.3% PFA, squares; 0.6% PFA, triangles; 1.2%
PFA, diamonds.
doi:10.1371/journal.pone.0024088.g010
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Glc-CFP/MBP-II
Glc-YFP interacting species. Moderate
digestion with factor Xa had nearly no effect on the positive
FRET signal of the interacting CFP/YFP species (Table 4).
However, extended digestion abolished such positive signals.
The results show that moderate digestion with factor Xa
(Figure 5) which affects release of a digested product with a
molecular weight of about 40 KDa, comparable to that of MBP,
did not affect the FRET signal, excluding the possible involvement
of fused MPB in the positive FRET signal of interacting species.
However, excessive digestion with factor Xa caused non specific
digestion and protein degradation accompanied by the disappear-
ance of the parent proteins, leaving a band with a molecular
weight of about 40 KDa, comparable to that of MBP (Figure 6).
Formaldehyde cross-linking studies of MBP-II
Glc
preparations, conducted both in vivo and in vitro
in vivo cross linking studies. In vivo cross linking caused a
change in the relative distribution of cell lysate components (low
speed pellets, high speed pellets and high speed supernatant)
(Figure 7). A decrease in the protein contents of these high speed
supernatants was demonstrated by in vivo cross linking, and this
decrease was proportional to the PFA concentration applied. On
the other hand, an increase in the protein content was
demonstrated in low and high speed pellets. Accordingly, PFA
treatment of growing cells caused agglomeration of soluble
proteins to give sedimentable proteins in both low and high
speed centrifugation. Concerning enzymatic activity of II
Glc, the
transphosphorylation activities of the three cell lysate fractions (low
speed pellets, high speed pellets and high speed supernatant)
(Figure 8) showed a dramatic reduction in the activities of low and
high speed pellets, even at low PFA concentrations, while the high
speed supernatant showed a lower reduction in activity which was
proportional to the PFA concentration. This differential reduction
in activity is attributed to the differential sensitivity of II
Glc of the
pellet fractions and that of the high speed supernatant. However,
the lower II
Glc activity of the high speed supernatant could be
attributed to a comparable decrease in the protein contents of the
HSS and/or to the action of PFA on II
Glc activity per se.
Figure 9 shows TP activity profiles of gel filtration fractions of
2 h high speed supernatants prepared from cultures of E. coli strain
BW25113DptsGDmalE::km(pMAL-ptsG) that were subjected to in
vivo cross linking with paraformaldehyde (PFA) at 0.3, 0.6 and
1.2%. In vivo treatment with PFA affected peak 1 activity much
more than peak 2 activity. Regarding the protein profile
(Figure 10), decreases in the protein content of the 2 h HSS
Figure 11. Effect of in vitro cross linking with different
concentrations of paraformaldehyde on transphosphorylation
activity of II
Glc peaks 1 (white bars) and 2 (black bars) from
E. coli BW25113DptsGDmalE::km(pMALE-ptsG). The 2 h HSS of a
crude cell lysate was gel filtered to get the two activity peaks 1 and 2.
Both peaks were subjected to in vitro cross linking as described in the
Methods section. The thin vertical lines above the histograms represent
error bars (S.D).
doi:10.1371/journal.pone.0024088.g011
Figure 12. Cryo-electron micrographs of purified II
Glc-MBP
preparations. E. coli strain BL21DE3(pMALE-ptsG) was used (A) pellet,
(B) peak 1, (C) peak 2, (D) buffer control.
doi:10.1371/journal.pone.0024088.g012
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proportional to the amount of PFA applied.
In vitro cross linking. In vitro treatment with PFA of peaks 1
and 2 of E. coli BW25113DptsGDmalE::km(pMAL-ptsG) (Figure 11)
showed again (see in vivo results for comparison) that peak 1 II
Glc
was more sensitive to PFA treatment compared than peak 2.
Lower concentrations of PFA (0.2 & 0.4%) caused a sharp
reduction in peak 1 TP activity while only a 30 to 35% reduction
in peak 2 activity was observed. Higher PFA concentrations (0.6 to
1.2%) dramatically affected the TP activities of both peaks
(Figure 11).
Relative sizes of MBP-II
Glc preparations determine by
cryo-electron microscopy and dynamic light scattering
(DLS)
Figure 12 shows cryo-electron micrographs of MBP-II
Glc
preparations obtained from pellet (A), Peak 1 (B) and Peak 2 (C).
The figure shows images of different appearances, all at the same
level of magnification. The pellets (A) revealed mostly spherical,
but also elongated structures, some of the former of which showed
central cavities indicative of vesicles. Peak 1 (B) revealed
heterogeneity with some spherical and many more elongated
particles. Thus, in contrast to Figure 12 (A), the particles are
predominantly elongated rather than spherical. In addition,
smaller particles not seen in Figure 12 (A) are present in large
numbers. The Peak 2 preparation (C) also shows heterogeneity,
but small particles predominate while only a few elongated or
spherical particles can be seen. These last mentioned structures
may have arisen during preparation (see Methods).
Dynamic light scattering [17,18] was also used to estimate
relative sizes and distributions of particles within these three
preparations. The results were obtained in terms of number,
intensity and volume (see Figure 13), and the Z average values
were also calculated [17,18]. Estimating the size distributions using
number, the value for the pellet peaked at 20.6 nm, that for Peak 1
was at 19.7 nm, and that for Peak 2 was at 11.5 nm.
Heterogeneity was apparent from the relative distributions of
particle sizes (28.2%, 21.0% and 15.7% for the three preparations,
respectively). Z average values for the three preparations were
103 nm, 96 nm and 78 nm for pellet, Peak 1 and Peak 2,
respectively. These and other relevant values are summarized in
Table 5. The results presented in this section provide relative size
distributions of particles within the three preparations, qualita-
tively in accordance with expectation.
NMR analyses correlated with enzyme activity
measurements
Figure 14 shows the results of
31P-NMR spectroscopic analyses
of five different preparations of the MBP-II
Glc fusion protein when
scanned at 37uC for 46,000 scans. The first fraction is the pellet,
obtained by high speed centrifugation followed by affinity
chromatography (see Methods). The remaining four fractions
were obtained by passage of the high speed supernatant (HSS)
through a Biogel 1.5 column, separating Peaks 1 and 2 by size
exclusion chromatography as reported previously[8]. Peak 1 was
subdivided into leading edge, central part, and trailing edge of this
peak, where approximately equal volumes of the three fractions
comprising Peak 1 were used. These were then re-purified by
affinity chromatography and analyzed both by
31P-NMR and by
enzyme assays. The latter were aimed at quantitating substrate
(glucose-6-P) inhibition, a measure of dimerization since only the
dimer exhibits this phenomenon [34]. Figure 14 (Pt) shows the
NMR spectrum of the phospholipids in the pellet fraction. A
typical spectrum normally observed for a bilayer was obtained; it
was skewed with an upfield chemical shift anisotrophy. The same
profile was obtained, skewed for the leading edge of Peak 1
(Figure 14 (P1-A)), and skewed with a high intensity peak (Figure 14
(P1-B)). By contrast, the trailing edge of Peak 1 as well as Peak 2
showed typical isotropic spectra with no chemical shift, charac-
teristic of micelles (Figures 14, P1-C and P2). The central part of
Peak 1 (Figure 14, P1-B) showed intermediate behavior, suggestive
of a mixed population or of an intermediate species. These results
provide convincing evidence that (1) lipids in the pellet are
essentially in bilayer form, as is true of the leading edge of Peak 1,
(2) lipids in the trailing edge of Peak 1 as well as Peak 2 are in
micellar form, and (3) the central part of Peak 1 exhibits an
Figure 13. Percentage distribution of II
Glc-MBP molecular sizes
of pellet (top), peak 1 (middle) and peak 2 (bottom)
preparations of E. coli strain BL21DE3(pMALE-ptsG) as deter-
mined by DLS. Values are expressed in volume (diamonds), intensity
(squares) and number (triangles).
doi:10.1371/journal.pone.0024088.g013
Table 5. Summary of DLS analyses.
Preparation Z-average Size distribution in terms of number
(nm) size (nm) Distribution (%)
Pellet 103.161.3 28.2 20.562.0
Peak 1 96.061.0 21.0 19.765.4
Peak 2 78.266.4 15.7 11.562.2
doi:10.1371/journal.pone.0024088.t005
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when the different preparations mentioned before were analyzed
at 25 and 45uC (Figures. S1, S2, S3, S4 and S5 at http://www.
biology.ucsd.edu/ ˜msaier/supmat/micellarPTS).
These five fractions were assayed for [
14C]-methyl a-glucoside
phosphorylation activity as a function of substrate (Glucose-6-P)
concentration. Surprisingly, pellet and all three Peak 1 fractions
showed essentially the same behavior (Figure 15 (A & B)). They
exhibited high activity at relatively low glucose-6-P concentrations,
but strong substrate inhibition at high glucose-6-P concentrations
[3,4,5,34,35]. Only peak 2 exhibited a lack of stubstrate inhibition,
and high activity was observed only at high sugar-phosphate
concentrations (Figure 15 (A)). Because substrate inhibition in the
transphosphorylation reaction is characteristic of the dimeric
enzyme and not the monomeric enzyme [1,2,3,35], we suggest
that while peak 2 is a micellar monomer, the trailing edge of Peak
1 contains a micellar dimer (see Discussion).
Polar phospholipid analyses of II
Glc-containing
preparations
The polar lipids were extracted from the various preparations
(a) whole E. coli membrane pellets (2 hr at 40,000 rpm, titanium
rotor; ,200,0006g); (b) the Biogel 1.5 column Peak 1 (gel
filtration), and (c) Biogel 1.5 column Peak 2. Each of these was
passed through an affinity amylose column (N.E. Biolabs #
E8021L) before being subjected to lipid extraction (see Methods).
Figure 14. [
31P]NMR spectra of purified II
Glc preparations of pellet (Pt), initial, middle and tail parts of peak 1 (P1-A, P1-B and P1-C,
respectively) and peak 2 (P2) of E. coli strain BW25113DptsGDmalE::km(pMALE-ptsG). The spectra were recorded at 37uC, 46,000 scans and
at an acquisition time of 1.6 seconds. Peak 2 was prepared from cells subjected to in vivo cross linking. For details see Materials and Methods. The
spectra of these tested preparations when examined at 25, 37 and 45uC and at different scans were shown in Figs. S1 to S5 (Saier’s web site).
doi:10.1371/journal.pone.0024088.g014
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18 show results of the three major E. coli phospholipids [PE
(Figure 16), PG (Figure 17) and CA (Figure 18)] for peak 1,
analyzed by liquid chromatography-mass spectrometry (LC-MS)
while the corresponding results for the standard, pellet and peak 2
preparations are shown in Figs. S6, S7, S8 (PE), S9 to S11 (PG)
and S12 to S14 (CA) at http://www.biology.ucsd.edu/ ˜msaier/
supmat/micellalPTS. The results clearly indicate that the
phospholipids in the membranes (pellet) occur in the proportions
of PE:PG:CL 61.8:21:17.2 which approximates the expected
Figure 15. Transphosphorylation (TP) activities of pellet (Top; A; squares) and Peak 2 (Top; A; triangles), as well as Peak 1
(A (leading edge; triangles), B (central part; x’s) and C (trailing edge; diamonds)) fractions (Bottom; B). Purified II
Glc-MBP was prepared
from E. coli strain BW25113DptsGDmalE::km(pMALE-ptsG). The radioactive substrate was 100 mM[
14C]methyl a-glucodside, used with different
concentrations of glucose-6-phosphate as indicated.
doi:10.1371/journal.pone.0024088.g015
Table 6. Relative ratios of PE, PG and CA and lipid/protein ratios of different EII
Glc-MBP preparations.
Preparation %PE %PG %CA PE/PG PE/CA PG/CA PE/(PG+CA) Lipid/protein (ng/ug)
Peak 2 - E. coli BL21DE3(pMALE-
ptsG) (induced prep)
51.3 28.5 20.1 1.8 2.5 1.4 1.0 5.3
Peak 1 E. coli BL21DE3(pMALE-
ptsG) (induced prep)
51.0 30.7 18.3 1.7 2.8 1.7 1.0 11.7
Pellet E. coli BL21DE3
(pMALE-ptsG) (induced prep)
61.8 21.0 17.2 2.9 3.6 1.2 1.6 32.3
Pellet E. coli BL21DE3
(pMALE-ptsG) (non-induced prep)
65.5 23.9 10.6 2.7 6.1 2.2 1.9 25.3
Pellet E. coli strain 301 (wild type) 64.5 22.5 12.9 2.8 5.0 1.7 1.8 46.8
Average Pellet 64.0 22.5 13.6 2.8 4.9 1.7 1.8 34.8
doi:10.1371/journal.pone.0024088.t006
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and P2 indicate that both of these fractions have decreased ratios
of zwitterionic (PE) phospholipid to anionic (PG + CL)
phospholipids. Surprisingly, these values were similar for Peaks 1
and 2.
The ratios of lipid to protein were also calculated (see
Table 6) showing that membranes possess the highest lipid:
protein ratios while Peak 2 has the lowest lipid:protein ratio
(pellet:P1:P2 =34.8:11.7:5.3). These results, taken together, imply
that the different preparations have differing phospholipid
compositions as well as different amounts of lipid per unit protein.
While Peaks 1 and 2 have similar lipid ratios, the lipid to protein
ratio of peak 2 is only half that of P1.
Discussion
In earlier publications we described the novel finding that
each of several integral membrane transport proteins of the
bacterial phosphotransferase system (PTS) can exist in a
soluble form. Evidence was presented that these soluble
Enzyme II complexes were present in the cytoplasm of intact
cells [1,2]. This last mentioned observation has been
confirmed in the present study, and we use a variety of
physical methods to characterize the various forms of the
glucose-specific Enzyme II complex (II
Glc). The approaches
used in this study included:
1. fluorescent energy transfer (FRET),
2. formaldehyde cross linking, both in vivo and in vitro,
3. measurements of enzyme activity and substrate inhibition,
4. cryo-electron microscopy (cryo-EM) and dynamic light scat-
tering (DLS) for particle size determination,
5. nuclear magnetic resonance (NMR),
6. measurements of relative amounts of the three principal E. coli
phospholipids, and
7. measurements of the phospholipid to protein ratios.
A brief summary of the results obtained with these seven
approaches is presented in Table 7.
Figure 16. LC-ESI-MS negative ion mode spectra of phosphatidylethanolamine (PE) molecular species of lipid extract of peak 1
fraction of E. coli strain BL21DE3(pMALE-ptsG). Arrows indicate different PE molecular species detected in peak 1 and standard preparations (for
standard preparation see Figure S6 at Saier web site). I.S., internal standard; right handed numbers at the top of the Y axis indicate full-scale intensity
in arbitrary units. The lipid contents of E. coli strain BL21DE3(pMALE-ptsG) were extracted and analyzed as described in Materials and Methods.
doi:10.1371/journal.pone.0024088.g016
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Glc molecules in peaks 1
and 2, based on FRET analyses
FRET analyses of mixtures of P1 CFP and P1 YFP fused
proteins, mixed before or after purification, showed no appreciable
FRET signals at the different tested protein concentrations and
ratios, suggesting the absence of intermolecular exchange between
the II
Glc proteins. However, when these same preparations were
exposed to Triton X100 before purification, FRET emission
spectra revealed excited state energy transfer. This indicates that
the II
Glc-CFP and II
Glc-YFP fused proteins were in direct contact.
Thus, detergent treatment of the stable dimeric mixed Peak 1 CFP
and YFP fusion proteins followed by purification on an amylose
resin must have caused dissociation to monomers and re-
association to give mixed dimers. These results attest to the
presence of stable dimers in Peak 1 II
Glc unless exposed to
detergent.
FRET analyses of mixtures of P2 CFP and P2 YFP fusion
proteins, mixed before or after purification and carried out at
different ratios of CFP/YFP in the total absence of detergent
yielded different results. When purified individually and mixed, no
FRET signal was observed, but when mixed and then purified,
FRET signals were observed. The most reasonable interpretation
is that the monomeric II
Glc of peak 2 is stable, but exposure to the
amylose resin causes these monomers to associate to dimers. This
result confirms earlier observations as reported in [1,2]. The
interpretation of this result will be presented below.
Formaldehyde crosslinking, electron microscopy,
dynamic light scattering and II
Glc activity measurements
Utilizing four very different techniques, formaldehyde cross-
linking, II
Glc activity measurements, cryo-electron microscopy and
dynamic light scattering (DLS) in combination, it was possible to
gain evidence for several novel features of the different forms
of II
Glc.
First, as expected from the centrifugation and gel filtration
results reported previously [1,2] it became clear from the
cryo-electron microscopy and DLS studies that the three
fractions, pellet, P1 and P2, showed very different properties.
The pellet consists mostly of large tubular and vesicular structures
characteristic of French Press disrupted E. coli membranes [38].
Figure 17. LC-ESI-MS negative ion mode spectra of phosphatidylglycerol (PG) molecular species of lipid extract of peak 1 fraction
of E. coli strain BL21DE3(pMALE-ptsG). Arrows indicate different PG molecular species detected in peak 1 and standard preparations (for
standard preparation see Figure S9 at Saier web site). Right handed numbers at the top of the Y axis indicate full-scale intensity in arbitrary units. The
lipid contents of E. coli strain BL21DE3(pMALE-ptsG) were extracted and analyzed as described in Materials and Methods.
doi:10.1371/journal.pone.0024088.g017
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substrate inhibition) in which it is very sensitive to formaldehyde
inactivation. P1 proved to also contain a mixture of membranous
vesicles and tubules, but more numerous smaller structures were
also detected. Based on the NMR results (see below), it appears
that many of these medium sized particles are present as dimeric
micelles. These putative dimeric micelles predominate in the
trailing edge of P1 while the larger membraneous particles
(presumably membrane vesicles) were found largely in the leading
edge of P1. P2 consists primarily of smaller particles, correspond-
ing to the expected size of lipid containing monomeric micelles.
These conclusions were substantiated by the substrate inhibition
analyses that showed that pellet and P1 show strong and similar
degrees of substrate inhibition while P2 showed none. Previous
studies have established that only the dimeric species of a PTS
Enzyme II complex exhibits this phenomenon [3,4,39].
Nuclear Magnetic Resonance (NMR) Data
Studies using
31P-NMR have proved of great value in
understanding the problems of lipid polymorphism in biological
membranes [40] and
31P-NMR is a powerful tool that can be used
to distinguish lipid bilayers from lipid micelles. When hydrated
phospholipid samples are subjected to
31P- NMR analysis under
conditions of proton decoupling (a process which removes the
dipolar interactions between protons and phosphorus nuclei) a
variety of spectral lineshapes may be encountered. These spectra
are sensitive indicators of the physical phase adopted by the lipids.
The NMR results showed that as expected, pellet and P2 were
present almost exclusively as bilayers and micelles, respectively.
Surprisingly, however, P1 also contains substantial amounts of
micelles especially in the trailing edge. This result was not
expected, because the Enzyme assays had shown that P1-II
Glc
exhibited substrate inhibition (characteristic of the dimer),
comparable to that of the pellet. This means that the micelles
present in P1 were most likely dimeric. This report therefore
provides the first evidence for dimeric micelles present in P1 but
not in appreciable amounts in the pellet or P2.
Occasionally, the isotropic peak 2 spectrum shows an additional
spectral component. Such a component was also observed by [41]
for micellar spectra and were interpreted as representing a tubular
lipid phase. Comparing the results obtained here with lipid
analysis data, it can be mentioned that the micellar structure
observed for P2 could be correlated with high anionic lipid (PG
and CL) content in peak 2 material relative to its PE content. This
suggests that a high (PG+CL)/PE ratio favors and stabilizes
micellar structure over bilayer structure. Such a conclusion is
supported by the following studies.
Kleinschmidt and Tamm [41] used solid-state
31P-NMR
spectroscopy to determine the minimal chain lengths of some
phospholipids that are required for the formation of lipid bilayers.
They found that when the chemical shift anisotropies (CSAs) of
lipids of the same chain length with different headgroups were
Figure 18. LC-ESI-MS negative ion mode spectra of cardiolipin (CA) molecular species of lipid extract of peak 1 fraction of E. coli
strain BL21DE3(pMALE-ptsG). Arrows indicate different CA molecular species detected in peak 1 and standard preparations (for standard
preparation see Figure S12 at Saier web site). I.S., internal standard; right handed numbers at the top of the Y axis indicate full-scale intensity in
arbitrary units. The lipid contents of E. coli strain BL21DE3(pMALE-ptsG) were extracted and analyzed as described in Materials and Methods.
doi:10.1371/journal.pone.0024088.g018
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spectra of bilayers) occurred in the order, PG , PE , PC
(phosphatidyl choline) , PS (phosphatidylserine). With the
exception of PE, this order correlated with the increasing volumes
of the lipid headgroups in this sequence. Accordingly, one would
generally expect to observe more order (larger CSA) for larger
headgroups. These investigators also noticed that the chain-length
threshold for bilayer formation follows a different order of
phospholipid classes, PE , PC , PS , PG. They reported that
in addition to headgroup volume, headgroup charge appears to
play an important role in explaining the micelle-to-bilayer
transition. Charge repulsion drives negatively charged PGs to
the micellar phase and thereby moves this lipid species to the right
end of the sequence. The primary amine-containing headgroups of
PE and PS can form hydrogen bonds with the phosphate groups of
neighboring lipids as demonstrated by crystallography [42],
infrared spectroscopy [43], and fluorescence spectroscopy
[44,45]. Hydrogen bonds can also be formed between the
hydroxyl groups and the phosphate groups of phosphatidylglycerol
molecules [46], but the negative charge remains effective as a
repulsive force between PG molecules. The hydrogen-bonding
interactions in PE and PS reduce the effective headgroup area and
thereby stabilize the bilayer over the micellar structure.
Lipid and Protein Analyses
All fractions were measured for total lipid and total protein
contents. The pellet fractions had the highest lipid to protein ratios
while P2 had the lowest such ratio. This fact correlated with our
earlier observation that phospholipids stimulate II
Glc activity in P2
much more than P1 or pellet II
Glc activity [1,2,7]. These
observations taken together suggest that a lipid deficiency
characterizes the monomeric micelles.
The micellar species proved to be enriched in anionic lipids, PG
and CL, and deficient for the zwitterionic lipid, PE. This can be
explained because II
Glc (and other PTS Enzymes II) require a
proper balance of PE versus PG+CL for optimal activity [2,21].
Thus, these enzymes exhibit depressed activity when either the
anionic or the zwitterionic lipids are lowered from their natural
amounts. The lower lipid to protein ratio in P2 may also
contribute to the reduced activity of this preparation.
The physiological impact of micellar species being enriched in
anionic lipids, PG and CL, may be of significance. Matsumoto
[47] reported that anionic phospholipids recruit peripheral
membrane proteins to the membrane by virtue of their negative
charges. For example, E. coli peripheral membrane proteins such
as SecA, FtsY, DnaA, PssA and HtrA (DegP) bind to negatively
charged surfaces. In the case of SecA, FtsY, DnaA and PssA, their
respective activities are dependent on their binding to major
anionic phospholipids. Accordingly, binding of FtsY to the
micellar II
Glc form might facilitate its insertion in the membrane
bilayer. This may be supported by the observation that precursor
proteins such as prePhoE and proOmpA were transported (SecA-
mediated translocation) across a PG-depleted membrane vesicle
when supplemented with CL, PA, phosphatidylserine (PS),
phosphatidylethanol or phosphatidylinositol (PI), essentially to
the same extent as PG-supplemented membranes [48,49]. The
FtsY protein, an E. coli homologue of the alpha-subunit of
eukaryotic signal recognition particle receptor, is suggested as
having a direct membrane targeting function in protein translo-
cation. In vitro, FtsY protein associates efficiently with membrane
vesicles containing 30% anionic PG [50]. As in the case of SecA,
the membrane association of FtsY is accompanied by a
conformational change required for membrane association. After
the proteins are recruited to the anionic surface of the membrane,
they are inserted into the acyl chain region of the phospholipid
bilayer [50,51,52]. These proteins are intimately associated with,
and surrounded by, hydrophobic acyl chains of phospholipids.
Overview
The application of physical techniques (FRET, cryo-EM, DLS
and NMR) together with standard biochemical approaches
(formaldehyde crosslinking, enzyme activity measurements and
phospholipid/protein determinations) allow us to come to novel
conclusions and hypotheses regarding the nature of the various
physical forms of II
Glc.
1. II
Glc can exist in 3 distinct forms: a dimer in a bilayer, a dimer
in a micelle, and a monomer in a smaller micelle.
2. Exchange of subunits within the dimer depends on the presence
ofdetergent (Triton X100), but coalescing ofmonomericmicelles
to form dimeric micelles can occur in the absence of detergent.
Table 7. Approaches used in this study and results obtained.
Technique Nature of the information obtained
1 Fluorescence energy transfer (FRET) Protein:protein interactions. Peak 2 can associate to peak 1 without detergent. Peak 1 cannot
dissociate to peak 2 without detergent.
2 Formaldehyde cross linking Protein:protein interactions. In vivo: peak 1 becomes insoluble with formaldehyde but peak 2 does
not. In vitro: peak 1 is inactivated; peak 2 is not.
3 Enzyme activity Dependency of substrate inhibition on monomeric versus dimeric form: identification of dimeric
micellar II
Glc.
4 Cryo-electron microscopy (C-EM) and
dynamic light scattering (DLS)
Purified French pressed membrane vesicles are heterogeneous; sizes: pellet. peak 1. peak 2
5 Nuclear magnetic resonance (NMR) Pellet is only in bilayer form. Peak 1, leading edge: only in bilayer form; peak 1 central part: mixture of
bilayer form and dimeric micelles; peak 1 trailing edge: dimeric micelles. Peak 2 monomeric micelles.
6 Lipid measurements Pellet: PE/PG =1.8
Peak 1: PE/PG =1.0
Peak 2: PE/PG =1.0
7 Lipid/protein measurements Pellet: lipid/protein (ng/mg) =35
Peak 1: lipid/protein (ng/mg) =12
Peak 2: lipid/protein (ng/mg) =5
doi:10.1371/journal.pone.0024088.t007
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substrate inhibition, is also much more sensitive to inactivation
by formaldehyde treatments.
4. Formaldehyde inactivation appears to occur with equal
efficiency when the dimer is present in a bilayer or micelle.
5. Particle size decreases in the expected order, pellet.P1.P2,
but all preparations are heterogeneous, probably representing
in part the ease of particle type interconversion.
6. Nuclear Magnetic Resonance is an ideal method for
distinguishing bilayers from micelles, and together with
substrate inhibition results, its use allowed us to provide
evidence for a previously unsuspected micellar dimeric
II
Glc.
7. The different fractions have different phospholipid:protein
ratios (pellet.P1.P2) and different phospholipid types, with
the PE contents being pellet.P1.P2.
These advances put the structural features of monomeric
and dimeric II
Glc micelles on a firm basis and allow us
to derive new questions that are subject to experimental
examination. The reasons why (1) the dimeric species
a r em o r es u s c e p t i b l et of o r m a l dehyde inhibition than the
monomeric forms, (2) why the monomeric micellar II
Glc has
more anionic phospholipids than the dimeric species, and (3)
what the basis for lipid depletion in the monomeric micellar
species have yet to be determined. Future studies will address
these questions.
Supporting Information
FigureS1 [
31P]NMR spectra ofpurified II
Glcpreparations
of pellet (Pt) fraction of E. coli strain BW25113DptsGDma-
lEKn-pMAL-ptsG. The spectra were recorded at different temper-
atures (25, 37, 45uC), an acquisition time of 1.6 seconds and 46,000
scans. The sample was exposed sequentially to the applied
temperatures. For details see Materials and Methods.
(TIF)
Figure S2 [
31P]NMR spectra of purified II
Glc prepara-
tion of initial (P1-A) fraction of peak 1 of E. coli strain
BW25113DptsGDmalEKn-pMAL-ptsG. The spectra were
recorded at different temperatures (25, 37, 45uC), an acquisition
time of 1.6 seconds and 46,000 scans. The sample was exposed
sequentially to the applied temperatures. For details see Materials
and Methods.
(TIF)
Figure S3 [
31P]NMR spectra of purified II
Glc prepara-
tion of middle (P1-B) fraction of peak 1 of E. coli strain
BW25113DptsGDmalEKn-pMAL-ptsG. The spectra were re-
corded at different temperatures (25, 37, 45uC), an acquisition time of
1.6 seconds and 46,000 scans. The sample was exposed sequentially
to the applied temperatures. For details see Materials and Methods.
(TIF)
Figure S4 [
31P]NMR spectra of purified II
Glc preparation
of tail (P1-C) fraction of peak 1 of E. coli strain
BW25113DptsGDmalEKn-pMAL-ptsG. The spectra were re-
corded at different temperatures (25, 37, 45uC), an acquisition time of
1.6 seconds and 46,000 scans. The sample was exposed sequentially
to the applied temperatures. For details see Materials and Methods.
(TIF)
Figure S5 [
31P]NMR spectra of purified II
Glc prepara-
tion of peak 2 of E. coli strain BW25113DptsGDmal-
EKn-pMAL-ptsG. The spectra were recorded at different
temperatures (25, 37, 45uC), an acquisition time of 1.6 seconds
and 46,000 scans. The sample was exposed sequentially to the
applied temperatures. For details see Materials and Methods.
(TIF)
Figure S6 LC-ESI-MS negative ion mode spectra of
phosphatidylethanolamine (PE) molecular species in
standard preparation. Arrows indicate different PE molecular
species detected. I.S., internal standard; right handed numbers at
the top of the Y axis indicate full-scale intensity in arbitrary units.
The analysis was done as described in Materials and Methods.
(TIF)
Figure S7 LC-ESI-MS negative ion mode spectra of
phosphatidylethanolamine (PE) molecular species of
lipid extract of pellet fraction of E. coli strain
BL21DE3-pMALptsG. Arrows indicate different PE molecular
species detected in pellet and standard preparations (for standard
preparation see Figure S6 at Saier web site). I.S., internal standard;
right handed numbers at the top of the Y axis indicate full-scale
intensity in arbitrary units. The lipid contents of E. coli strain
BL21DE3-pMALptsG were extracted and analyzed as described in
Materials and Methods.
(TIF)
Figure S8 LC-ESI-MS negative ion mode spectra of
phosphatidylethanolamine (PE) molecular species of
lipid extract of peak 2 fraction of E. coli strain
BL21DE3-pMALptsG. Arrows indicate different PE molecular
species detected in peak 2 and standard preparations (for standard
preparation see Figure S6 at Saier web site). I.S., internal standard;
right handed numbers at the top of the Y axis indicate full-scale
intensity in arbitrary units. The lipid contents of E. coli strain
BL21DE3-pMALptsG were extracted and analyzed as described in
Materials and Methods.
(TIF)
Figure S9 LC-ESI-MS negative ion mode spectra of
phosphatidylglycerol (PG) molecular species of standard
preparation. Arrows indicate different PG molecular species
detected. I.S., internal standard; right handed numbers at the top
of the Y axis indicate full-scale intensity in arbitrary units. The
analysis was carried out as described in Materials and Methods.
(TIF)
Figure S10 LC-ESI-MS negative ion mode spectra of
phosphatidylglycerol (PG) molecular species of lipid
extract of pellets fraction of E. coli strain BL21DE3-
pMALptsG. Arrows indicate different PG molecular species
detected in pellet and standard preparations (for standard
preparation see Figure S9 at Saier web site). Right handed numbers
at the top of the Y axis indicate full-scale intensity in arbitrary units.
The lipid contents of E. coli strain BL21DE3-pMALptsG were
extracted and analyzed as described in Materials and Methods.
(TIF)
Figure S11 LC-ESI-MS negative ion mode spectra of
phosphatidylglycerol (PG) molecular species of lipid
extract of peak 2 fraction of E. coli strain BL21DE3-
pMALptsG. Arrows indicate different PG molecular species
detected in peak 2 and standard preparations (for standard
preparation see Figure S9 at Saier web site). Right handed
numbers at the top of the Y axis indicate full-scale intensity in
arbitrary units. The lipid contents of E. coli strain BL21DE3-
pMALptsG were extracted and analyzed as described in Materials
and Methods.
(TIF)
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cardiolipin (CA) molecular species of standard prepa-
ration. Arrows indicate different CA molecular species detected.
I.S., internal standard; right handed numbers at the top of the Y
axis indicate full-scale intensity in arbitrary units. The analysis was
carried out as described in Materials and Methods.
(TIF)
Figure S13 LC-ESI-MS negative ion mode spectra of
cardiolipin (CA) molecular species of lipid extract of
pellets fraction of E. coli strain BL21DE3-pMALptsG.
Arrows indicate different CA molecular species detected in pellet
and standard preparations (for standard preparation see Figure
S12 at Saier web site). I.S., internal standard; right handed
numbers at the top of the Y axis indicate full-scale intensity in
arbitrary units. The lipid contents of E. coli strain BL21DE3-
pMALptsG were extracted and analyzed as described in Materials
and Methods.
(TIF)
Figure S14 LC-ESI-MS negative ion mode spectra of
cardiolipin (CA) molecular species of lipid extract of
peak 2 fraction of E. coli strain BL21DE3-pMALptsG.
Arrows indicate different CA molecular species detected in peak 2
and standard preparations (for standard preparation see Figure
S12 at Saier web site). I.S., internal standard; right handed
numbers at the top of the Y axis indicate full-scale intensity in
arbitrary units. The lipid contents of E. coli strain BL21DE3-
pMALptsG were extracted and analyzed as described in Materials
and Methods.
(TIF)
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